Human globin chain separation by isolectric focusing

Pier Giorgio Righetti(Giuliani (Italy)), L. Rossi-Bernardi(University of Milan), Paola Comi(University of Milan), Elisabetta Gianazza(University of Milan), Alessandro M. Gianni(University of Milan), Barbára Giglioni, Camillo Secchi(University of Milan), Sergio Ottolenghi(University of Milano-Bicocca)

Journal of Biochemical and Biophysical Methods

March 1, 1979

10.1016/0165-022x(79)90045-9

Cited by 95

Related Papers

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

|Blood|2008|253

Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With Lymphoma

|Journal of Clinical Oncology|2010|167

Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial

|The Lancet Oncology|2012|145

Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells

|Biochemical Pharmacology|2007|118

Senescence-Dependent Regulation of Type 1 Plasminogen Activator Inhibitor in Human Vascular Endothelial Cells

|Experimental Cell Research|1995|110